How ALS Progresses on Genetic and Cellular Level Revealed by High-Res Spinal Cord Study
Simons Foundation, April 2019Precise experiments have revealed for the first time how Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), progresses on a genetic and cellular level. The work opens new avenues for developing potential treatments for the disease, which affects around 450,000 people worldwide.